NCT02623075View on ClinicalTrials.gov

Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 5, 2016

Study Completion Date

December 31, 2023

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza vaccine

Blood samples will be collected at research study visits at 0 and 30 days (+/- 2 days) post-IIV4 (influenza vaccine). Collection will be as follows: 45-50 ml blood at each visit (not to exceed more than three visits over a two month period).

Trial Locations (1)

60611

Northwestern University Comprehensive Transplant Center, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT02623075 - Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients | Biotech Hunter | Biotech Hunter